LEADER 01493nam  2200421z- 450 
001 9910689897103321
005 20161209104225.0
035   $a(CKB)5860000000027531
035   $a(BIP)011441523
035   $a(EXLCZ)995860000000027531
100   $a20220406c2004uuuu  -u-         -
101 0 $aeng
200 14$aThe law of biologic medicine $ehearing before the Committee on the Judiciary, United States Senate, One Hundred Eighth Congress, second session, June 23, 2004
215   $a1 online resource (iii, 159 p.) 
311   $a0-16-073731-1 
517   $aLaw of biologic medicine 
606   $aPharmaceutical biotechnology$xLaw and legislation$zUnited States
606   $aDrugs$xLaw and legislation$zUnited States
606   $aPatent laws and legislation$zUnited States
606   $aGeneric drugs$zUnited States
610   $aUnited States
610   $aPharmaceutical biotechnology
610   $aDrugs
610   $aPatent laws and legislation
610   $aGeneric drugs
610   $aPolitical science
610   $aTechnology & engineering
610   $aLaw
610   $aMedical
615  0$aPharmaceutical biotechnology$xLaw and legislation
615  0$aDrugs$xLaw and legislation
615  0$aPatent laws and legislation
615  0$aGeneric drugs
712 02$aUnited States, Congress Senate Committee on the Judiciary Staff,$4oth
906   $aBOOK
912   $a9910689897103321
996   $aThe law of biologic medicine$93127786
997   $aUNINA